Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2010 May 18;9(6):1596–1608. doi: 10.1158/1535-7163.MCT-09-1146

Figure 6. BITC treatment suppress the expression of NF-kB, cyclin D1, HDAC1 and HDAC3 in vivo.

Figure 6

Tumor sections from control and 12μmol BITC treated mice were analyzed for the expression of NF-kB, cyclin D1, HDAC1 and HDAC3 by immunohistochemistry. Each section was analyzed under the microscope at 200 x magnification.